These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
12. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294 [TBL] [Abstract][Full Text] [Related]
13. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634 [TBL] [Abstract][Full Text] [Related]
16. Two cases from the spectrum of nonalcoholic steatohepatitis. Abdelmalek M; Ludwig J; Lindor KD J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192 [TBL] [Abstract][Full Text] [Related]